Medipharm Labs Corp (LABS) — Cash Flow Reinvestment Rate
Medipharm Labs Corp (LABS) has a Cash Flow Reinvestment Rate of 0.23x as of December 2025, reinvesting CA$100.00K (capex CA$100.00K ) from operating cash flow of CA$435.00K. Check LABS cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Medipharm Labs Corp Cash Flow Reinvestment Rate (2017–2017)
Historical reinvestment intensity for Medipharm Labs Corp across 1 annual periods. Explore LABS strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Medipharm Labs Corp (2017–2017)
Year-by-year capital reinvestment analysis for Medipharm Labs Corp. For live market cap and broader valuation context, see Medipharm Labs Corp (LABS) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CAD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2017 | 13.22x | CA$2.19 Million | CA$166.00K | CA$2.14 Million | — |